Mylan Pharmaceuticals is a multi-billion dollar company that produces pharmaceuticals worldwide. The company produces EpiPens, an epinephrine autoinjector for people with life threatening allergies. Mylan recently raised the price of Epipens from $100 to $608.61 a pair (Bloomberg). Some would say that Mylan’s EpiPen is a virtual monopoly. Consumers and the community are crucial stakeholders in any company and Mylan is being unethical to both of them. They have complete control over the epinephrine industry. For people with life threatening allergies, EpiPens are a necessity. Mylan can set the price of these drugs as high as they would like because people will always need to buy them and no other company has been able to compete. The
